XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 47,537 $ 9,052
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 100,594 111,479
Non-cash operating lease costs 5,538 5,924
Share-based compensation 20,472 17,619
Provision for credit losses on accounts receivable 1,336 1,819
Deferred income taxes, net (7,869) (18,330)
Loss on sale of businesses 3,780 0
(Gain) loss from equity method investments (8,172) 9,755
Unrealized loss on short-term investments held at the reporting date, net 10,705 23,541
Gain on investments (3,051) (357)
Other 1,779 3,834
Decrease (increase) in:    
Accounts receivable 44,215 20,470
Prepaid expenses and other current assets (9,138) (13,038)
Other assets (375) (4,030)
Increase (decrease) in:    
Accounts payable (80,548) (1,332)
Deferred revenue 13,108 (1,777)
Accrued liabilities and other current liabilities (13,789) (9,594)
Net cash provided by operating activities 126,122 155,035
Cash flows from investing activities:    
Purchases of property and equipment (53,633) (55,250)
Acquisition of businesses, net of cash received (56,698) (9,492)
Proceeds from sale of equity investments 19,455 3,174
Proceeds from sale of businesses, net of cash divested 7,860 0
Other (124) (3,753)
Net cash used in investing activities (83,140) (65,321)
Cash flows from financing activities:    
Repurchase of common stock (87,928) (62,678)
Issuance of common stock under employee stock purchase plan 4,525 4,724
Deferred payments for acquisitions (7,417) (6,679)
Other (940) 21
Net cash used in financing activities (91,760) (64,612)
Effect of exchange rate changes on cash and cash equivalents (1,600) 1,195
Net change in cash and cash equivalents (50,378) 26,297
Cash and cash equivalents at beginning of period 737,612 652,793
Cash and cash equivalents at end of period $ 687,234 $ 679,090